Stocks and Investing Stocks and Investing
Thu, July 23, 2020

David Toung Maintained (ABT) at Strong Buy with Increased Target to $125 on, Jul 23rd, 2020


Published on 2024-10-27 10:17:09 - WOPRAI, David Toung
  Print publication without navigation


David Toung of Argus Research, Maintained "Abbott Laboratories" (ABT) at Strong Buy with Increased Target from $110 to $125 on, Jul 23rd, 2020.

David has made no other calls on ABT in the last 4 months.



There are 11 other peers that have a rating on ABT. Out of the 11 peers that are also analyzing ABT, 1 agrees with David's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • Danielle Antalffy of "SVB Leerink" Maintained at Hold with Increased Target to $110 on, Friday, July 17th, 2020


These are the ratings of the 10 analyists that currently disagree with David


  • David Lewis of "Morgan Stanley" Maintained at Buy with Increased Target to $106 on, Friday, July 17th, 2020
  • Joanne Wuensch of "Citigroup" Maintained at Strong Buy with Increased Target to $110 on, Friday, July 17th, 2020
  • John Sourbeer of "UBS" Maintained at Strong Buy with Increased Target to $110 on, Friday, July 17th, 2020
  • Matt Miksic of "Credit Suisse" Maintained at Buy with Increased Target to $109 on, Friday, July 17th, 2020
  • Larry Biegelsen of "Wells Fargo" Maintained at Buy with Increased Target to $122 on, Friday, July 10th, 2020
  • Matthew Taylor of "UBS" Maintained at Strong Buy with Increased Target to $109 on, Friday, April 17th, 2020
  • Raj Denhoy of "Jefferies" Maintained at Strong Buy with Increased Target to $113 on, Friday, April 17th, 2020
  • Rick Wise of "Stifel" Maintained at Strong Buy with Increased Target to $108 on, Friday, April 17th, 2020
  • Jayson Bedford of "Raymond James" Maintained at Buy with Increased Target to $102 on, Friday, April 17th, 2020
  • Kevin Huang of "CFRA" Maintained at Strong Buy with Increased Target to $101 on, Thursday, April 16th, 2020

Contributing Sources